Live Breaking News & Updates on Global Blood Therapeutics|Page 8

Stay updated with breaking news from Global blood therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UCB departs biotech trade group BIO

UCB left the biotech industry group BIO at the end of 2023, the second major member company to exit after Pfizer pulled out. ....

United States , Erica Puntel , Global Blood Therapeutics , Chair Ted Love ,

Pfizer Stock: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations (PFE)

Pfizer Stock: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations (PFE)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United States , Novo Nordisk Norditropin , Eli Lilly Verzenio , Merck Keytruda , Arena Pharmaceuticals , Biohaven Pharmaceuticals , Pfizer Near Term Launches , High Value Pipeline , World Is Gaining , Bristol Myers Squibb , Novo Nordisk , Seeking Alpha , Global Blood Therapeutics , Novarti Kisqali , Eli Lilly , Inflation Reduction Act , Inflation Reduction ,

Patients with sickle cell disease using disease-modifying therapies more, but not enough

Patients with sickle cell disease using disease-modifying therapies more, but not enough
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United States , Byjosh Friedman , Mindy Valcarcel , University Of Pittsburgh School Pharmacy , Global Blood Therapeutics , Victoria Newman , Clinformatics Data Mart Database ,

Factbox-How Pfizer is fortifying for growth beyond COVID products

The company on Wednesday forecast revenue from its COVID-19 vaccine and treatment to be $8 billion in 2024, a far cry from the $57 billion in 2022. In March, Pfizer announced a $43 billion acquisition of drugmaker Seagen to bring into its fold four approved cancer therapies. Last year, the company struck an $11.6 billion deal for migraine drug maker Biohaven Pharmaceutical Holding and bought Global Blood Therapeutics for $5.4 billion, adding sickle cell disease treatment Oxbryta to its pipeline. ....

United States , Khushi Mandowara , Sriraj Kalluvila , Manas Mishra , Damien Conover , Caribou Sciences , Biohaven Pharmaceutical Holding , Global Blood Therapeutics , Akero Therapeutics , United Kingdom , Global Blood Therapeutics , Biohaven Pharmaceutical Holding , Biohaven Pharmaceutical , Cost Cutting , Aribou Sciences And Akero Therapeutics ,

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Saint Patrick , New Yorker , Kevin Davies , Verne Mason , Linus Pauling , Vernon Ingram , Edward Jenner , James Herrick , Emily Whitehead , Jennifer Doudna , Louise Brown , Johns Hopkins , Anthony Allison , Patrick Mcgann , Haydar Frangoul , John Evans , Francis Collins , Rube Goldberg , Erica Esrick , David Williams , Emmanuelle Charpentier , Dhruv Khullar , David Altshuler , John Tisdale ,